|
The COVID-19 pandemic has fundamentally changed the way people live and work around the world. There is a huge demand to expand the diagnostic capacity.
|
|
Sino Biological's Novel COVID-19 Immunodiagnostic webinar series provides a platform where new technologies can be shared among research and industrial leaders. The invited speakers are industrial and academic scientists working on a variety of novel diagnostic assays. The scope of the webinars includes assays that:
1. detect the virus itself, or viral antigens, with high specificity and sensitivity
2. can allow high-throughput testing
3. can simultaneously detect multiple antigens and/or antibodies
4. use different detection systems than colloidal gold
|
|
Registration:
The webinars will take place from 7/21/2020 to 8/13/2020. To register, please click the “register” button below to get the entry link. All webinars will be held on ZOOM.
|
|
|
|
|
|
|
Rapid and Quantitative Detection of SARS-CoV-2 Specific IgG for Convalescent Plasma Therapy
Xiaotian Tan, Ph.D. - Research Fellow University of Michigan
|
|
|
|
|
|
|
|
|
Frequency of Direct Antigen Rapid Testing for COVID-19 Reduces Transmission
Bobby Brooke Herrera, Ph.D. - Co-founder & Interim CEO, CSO, E25Bio, Inc.
Visiting Scientist, Harvard T.H. Chan School of Public Health
|
|
|
|
|
|
|
|
|
High-Accuracy Multiplexed SARS-CoV-2 Antibody Assay with Avidity and Saliva Capability on a Nano-Plasmonic Platform
Meijie Tang, Ph.D. - CEO, Nirmidas Biotech Inc.
Hongjie Dai, Ph.D. - Professor, Department of Chemistry and Bio-X, Stanford University
|
|
|
|
|
|
|
|
|
Next Generation BLI: Novel Applications in the Fight against COVID-19
Kathryn E Livingston, Ph.D. - Product Manager
Gator Bio
|
|
|
|
|
|
Watch On-demand
|
|
These webinars are over now. To watch on-demand, please click the "Watch" button below.
|
|
|
|
|
Analyzing the Human Antibody Response to Pandemic Respiratory Viruses with Adarza's New ZIVA™ Platform and High Definition Antigen Arrays: A Case Study on COVID-19
|
|
|
|
|
|
Cytokine Biomarkers of Inflammatory Response in COVID-19 Patients
|
|
|
